SCHEMBL30889392

SCHEMBL30889392

C[C@@H](N)c1cnc2ccc(Cl)cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.46
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
HRH4 Q9H3N8 2/20 0.36
HTR3A P46098 2/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
FGFR3 P22607 1/20 0.35
KDR P35968 1/20 0.35
PIK3CG P48736 2/20 0.35
NR4A2 P43354 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTR3E A5X5Y0 1/20 0.34
HTR3B O95264 1/20 0.34
BACE1 P56817 1/20 0.34
HTR3D Q70Z44 1/20 0.34
HTR3C Q8WXA8 1/20 0.34
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28162160 1.00 ADRB2 (0.46) ADRB2TP53LMNAHTTHRH4
SCHEMBL28161658 1.00 ADRB2 (0.46) ADRB2TP53LMNAHTTHRH4
SCHEMBL30315766 1.00 ADRB2 (0.46) ADRB2TP53LMNAHTTHRH4
SCHEMBL28161657 1.00 ADRB2 (0.46) ADRB2TP53LMNAHTTHRH4
SCHEMBL20009337 0.86 HRH4 (0.38) TP53LMNAHRH4HTR3AFGFR3
SCHEMBL1253863 0.77 CYP1A2 (0.53) HTR3AALDH1A1PDGFRBPDGFRACYP1A2
SCHEMBL30447104 0.77 CYP1A2 (0.53) HTR3AALDH1A1PDGFRBPDGFRACYP1A2
SCHEMBL28467592 0.77 CYP1A2 (0.53) HTR3AALDH1A1PDGFRBPDGFRACYP1A2
SCHEMBL20023742 0.77 CYP1A2 (0.53) HTR3AALDH1A1PDGFRBPDGFRACYP1A2
SCHEMBL30239388 0.77 CYP1A2 (0.53) HTR3AALDH1A1PDGFRBPDGFRACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12275715-B2 Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors FORMA THERAPEUTICS, INC. (US) 2025-04-15 US disclosed
US-20240150319-A1 PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2024-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12275715-B2 Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors IDH1, IDH3A, IDH2 ADRB2 4465/4885TP53 60/4885LMNA 1992/4885
US-20240150319-A1 PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS IDH1, IDH3A, IDH2 ADRB2 4465/4885TP53 60/4885LMNA 1992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.